All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

Changing Fate of Bone-Related Therapies for Prostate Cancer

October 18th 2011

Two trials are underway that not only address bone-related issues but might improve survival rates for patients.

How's Your State Doing in Palliative Care?

October 17th 2011

The 2011 State-by-State Palliative Care Report Card is now available for viewing.

Vitamin E Supplements Linked to Increased Risk of Prostate Cancer

October 12th 2011

Vitamin E may increase the risk of developing prostate cancer in men who have taken the supplement for 5 years or longer.

Prostate Cancer Screening

October 10th 2011

The USPSTF releases its new recommendations for public comment.

Effectiveness of Adriamycin Questioned in the Treatment of Patients With HER2-Positive Breast Cancer

October 7th 2011

HER2-positive women can be effectively treated with Herceptin (trastuzumab injection) without the use of Adriamycin.

Welcome to UCD ChestHealth!

October 3rd 2011

Welcome to UCD ChestHealth, the official blog of UC Davis Thoracic Surgery.

Smoking Rates Released

October 3rd 2011

Do you know who has the highest---and lowest---smoking rates in the US?

New Frontiers in the Management of Solid and Liquid Tumors Letter from Andre Goy, MD, MS

October 1st 2011

A Letter from Andre Goy, MD, MS, about the New Frontiers in the Management of Solid and Liquid Tumors in November.

Compassionate Care

September 27th 2011

We may think we're delivering compassionate care, but the public feels otherwise.

Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients

September 26th 2011

Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially for women with early breast cancer.

Joint Commission Names Top-Performing Hospitals

September 22nd 2011

The Joint Commission has released this year's list of top-performing hospitals.

Number of Lymph Nodes Examined for Colon Cancer Increases but Proportion of Node-Positive Cancers Does Not

September 14th 2011

A greater number of lymph nodes are being screened in colon cancer but this has not led to more diagnoses of node-positive colon cancer.

Detecting Early Stage Pancreatic Cancer

September 12th 2011

Combination of CA 19-9 tumor marker level and endoscopic ultrasound may aid in early detection in high-risk individuals.

Breast Cancer Study Supports Role of Mammography, Self-Exams

September 7th 2011

Detecting breast cancer using mammography and self-examination was affirmed in a study that sharply contrasts the controversial 2009 USPSTF recommendations.

New Nomogram Tools Predict Risk of Lymphedema

September 6th 2011

A new set of statistical models will soon be available to help predict the risk of lymphedema for patients with breast cancer who have undergone ALND.

Breast-Conserving Therapy Outcomes Deemed Similar to Mastectomy

September 6th 2011

Women age 40 and younger with breast cancer experience similar outcomes in local recurrence and survival rates whether they undergo BCT or a mastectomy.

Yoga Research Study 1: Peaceful Play Yoga

September 6th 2011

Offering yoga to children living with cancer is an exciting opportunity for registered nurses to learn about and to practice.

Wrong-site Surgery

September 6th 2011

Wrong-site surgery is still occurring despite wide adoption of prevention strategies.

Xalkori: A Revolution in Lung Cancer Treatment

August 30th 2011

While smoking and lung cancer have always been closely linked, recent advances in research have begun to unravel the genetic code behind the disease.

FDA Approves Crizotinib for Late-Stage Non-Small Cell Lung Cancer

August 26th 2011

On Friday, August 26, 2011, the FDA approved crizotinib (Xalkori) to treat ALK-positive patients with late-stage non–small cell lung cancer (NSCLC).